David Scott Miller, MD, FACOG, FACS
@dsmgyo.bsky.social
📤 86
đź“Ą 54
đź“ť 12
Gynecologic oncologist & professor.
#Lenvatinib
plus
#pembrolizumab
in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
jitc.bmj.com/content/14/2...
#clinicaltrial
#endometrialcancer
loading . . .
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
Background In Study 309/KEYNOTE-775 ( NCT03517449), lenvatinib+pembrolizumab versus chemotherapy significantly improved progression-free survival (PFS), overall survival (OS), and objective response r...
https://jitc.bmj.com/content/14/2/e013713
3 months ago
0
0
0
reposted by
David Scott Miller, MD, FACOG, FACS
Chris McCabe
4 months ago
Resist and Unsubscribe: The Economic Strike Against ICE - YouTube
www.youtube.com/watch?v=5o_o...
loading . . .
Resist and Unsubscribe: The Economic Strike Against ICE
YouTube video by The Prof G Pod – Scott Galloway
https://www.youtube.com/watch?v=5o_oNlclPHQ
0
1
1
Things can be done
add a skeleton here at some point
4 months ago
0
0
0
Now open at UT Southwestern Simmons Cancer Center.
#gyncsm
#clinicaltrial
add a skeleton here at some point
4 months ago
0
0
0
Missed the
@nrgonc.bsky.social
General Session? Is your site high performing? Check the website next week for the posting of the membership and quality report.
#NRG2026
add a skeleton here at some point
4 months ago
0
0
0
Are you a high accruing
@nrgonc.bsky.social
site?
add a skeleton here at some point
4 months ago
0
0
0
reposted by
David Scott Miller, MD, FACOG, FACS
Velindre Library
6 months ago
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).
ascopubs.org/doi/10.1200/...
loading . . .
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)
PURPOSELow-grade serous carcinoma (LGSOC) of the ovary, fallopian tube, or peritoneum is a hormonally driven, relatively chemoresistant malignancy with limited treatment options in the recurrent setti...
https://ascopubs.org/doi/10.1200/JCO-25-01348
0
2
1
reposted by
David Scott Miller, MD, FACOG, FACS
Dee Sparacio
9 months ago
Latest blog post for
#GCAM
Diagnosis, stages and types
womenofteal.blogspot.com/2025/09/gcam...
#gyncsm
loading . . .
#GCAM Diagnosis and Types and Stages of Ovarian Cancer
I spoke about how there are symptoms of ovarian cancer( gloating, freq urination etc) in my previous post. What happens when you go to your ...
https://womenofteal.blogspot.com/2025/09/gcam-diagnosis-and-types-and-stages-of.html
0
3
1
reposted by
David Scott Miller, MD, FACOG, FACS
FactCheck.org
8 months ago
Trump Administration’s Problematic Claims on Tylenol and Autism
www.factcheck.org/2025/09/trum...
0
15
8
It’s Gynecologic cancer awareness month!
#GCAM
add a skeleton here at some point
9 months ago
1
5
0
reposted by
David Scott Miller, MD, FACOG, FACS
John Cooper
10 months ago
Health care CEOs harvest billions even as industry lags broader stock market
www.statnews.com/2025/08/18/h...
via
@statnews.com
loading . . .
Health care CEOs harvest billions even as industry lags broader stock market
STAT dug into the compensation of 275 CEOs across health care.
https://www.statnews.com/2025/08/18/healthcare-executive-compensation-biontech-ceo-sahin-tops-list/
1
3
2
reposted by
David Scott Miller, MD, FACOG, FACS
Torr (I moved to Threads)
10 months ago
WSJ's Chief Economics Commentator: "The U.S. Marches Toward State Capitalism With American Characteristics - Trump is imitating the Chinese Communist Party by extending political control ever deeper into the economy."
www.wsj.com/economy/the-...
loading . . .
The U.S. Marches Toward State Capitalism With American Characteristics
President Trump is imitating the Chinese Communist Party by extending political control ever deeper into the economy.
https://www.wsj.com/economy/the-u-s-marches-toward-state-capitalism-with-american-characteristics-f75cafa8?st=V94Pvb&reflink=desktopwebshare_permalink
2
8
14
Interested in
@nrgonc.bsky.social
membership?
add a skeleton here at some point
10 months ago
1
5
0
reposted by
David Scott Miller, MD, FACOG, FACS
ProPublica
11 months ago
👇 Our reporters uncovered the payment at the center of this story with the help of our own Nonprofit Explorer tool — and its handy filing text search option. Researchers and journalists, check it out below.
add a skeleton here at some point
66
1281
486
In Chicago for
#ASCO25
? Drop by one of our presentations.
add a skeleton here at some point
about 1 year ago
0
6
0
reposted by
David Scott Miller, MD, FACOG, FACS
NRGOnc
about 1 year ago
NRG Oncology (& our foundations, GOG, NSABP,
@rtogfoundation.bsky.social
) research being presented at the hashtag#ASCO25 meeting:
ow.ly/AyuN50VY12m
0
1
2
reposted by
David Scott Miller, MD, FACOG, FACS
The New York Times
about 1 year ago
Texas lottery executives blessed a scheme that ensured one player would win a $95 million jackpot in 2023. In a state known for its aversion to government regulation, the successful manipulation has taken on deep meaning.
nyti.ms/4jdtZ3X
155
3310
1351
Comparing
#durvalumab
,
#olaparib
, and
#cediranib
, or chemotherapy in platinum-resistant
#ovariancancer
: the
@nrgonc.bsky.social
GY023 trial url:https://aacrjournals.org/clincancerres/article-abstract/doi/10.1158/1078-0432.CCR-24-3877/755490/Comparing-durvalumab-olaparib-and-cediranib
#gyncsm
about 1 year ago
0
2
0
Daniela Matei on Chemotherapy for Stage III Endometrial Cancer. The long-term results of @GOG 258 from the
@nrgonc.bsky.social
Uterine Corpus Committee. Now in print in @JCO_ASCO. From
@medpagetoday.bsky.social
.
www.medpagetoday.com/reading-room...
#gyncsm
#clinicaltrials
#endometrialcancer
loading . . .
Daniela Matei on Chemotherapy for Stage III Endometrial Cancer
Long-term data confirm: added pelvic RT conferred no survival benefit; chemotherapy remains the mainstay for these patients
https://www.medpagetoday.com/reading-room/asco/gynecological-cancers/115015
about 1 year ago
0
4
1
Patient advocates make a difference for
@nrgonc.bsky.social
. Thank you
@tambre.bsky.social
&
@heidi-drrn.bsky.social
!
add a skeleton here at some point
about 1 year ago
0
3
1
you reached the end!!
feeds!
log in
